Age: 87.0
Sex: M
Vaccine: VARZOS, VARZOS
Symptoms: Blindness unilateral, Corneal oedema, Eye pain, Slit-lamp examination, Vision blurred
Clinical narrative: This case was reported by a pharmacist and described the occurrence of blurred vision in a 87-year-old male patient who received SHINGRIX for prophylaxis. The patient's past medical history included rosacea (with itchy and scratchy symptoms). Concurrent medical conditions included glaucoma and blepharitis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, 1 day after receiving SHINGRIX, the patient experienced blurred vision (serious criteria other: as per reporter), eye pain (serious criteria other: as per reporter), ocular discomfort (serious criteria other: as per reporter) and corneal edema (serious criteria other: as per reporter). On an unknown date, the outcome of the blurred vision, eye pain, ocular discomfort and corneal edema were unknown. It was unknown if the reporter considered the blurred vision, eye pain, ocular discomfort and corneal edema to be related to SHINGRIX. Additional details were reported as follows: This case was reported by the patient who was a retired pharmacist. The patient believed to have a serious side effect and described as lost most of the vision in the left eye. So the patient treated the symptoms as previously did for the itchy, scratchy symptoms expecting the symptoms to disappear. However, the symptoms only got worse. The patient's left eye became painful and extremely uncomfortable. The patient went back to see the ophthalmologist. The ophthalmologist was on vacation at the time, so the patient saw the optometrist who did not know why the vision was so blurry. The patient could not read the largest letter on the chart with the left eye. The patient saw another ophthalmologist, and other eyes doctors until the patient's ophthalmologist returned from the vacation and the patient saw him several times who did not know what caused the condition. The patient reported to the ophthalmologist that, SHINGRIX was the only change in medication. The patient was referred to a cornea specialist. He saw the patient 3 times once with the swollen cornea, another time when the patient was off glaucoma drops for a week as recommended by the regular eye doctor. This doctor stated, the patient needed a cornea transplant. The patient agreed and saw him 3rd time. The doctor examined the patient and reconsidered stating that, a transplant would not help and might make the glaucoma worse. The patient went back to the regular eye doctor who disagreed somewhat and referred the patient to another cornea specialist. The patient scheduled an appointment with another cornea specialist on 30th July 2018. The patient would like to know if there were any reported side effects with SHINGRIX that related to the patient's condition. The patient did not believe any signs of herpes or rosacea were seen in the eyes when examined with a slit lamp. The patient spoke to one of the primary care doctors who was concerned and added that, the patient would not be protected from Shingles without the second shot. The patient had only briefly outlined the circumstances here. All which transpired over the past few months beginning the day after the SHINGRIX vaccine. The patient's left eye did not appear to get worse at the reporting time but the patient cannot see through it. The patient would report the experience to other agencies in the event his symptoms might had been reported by others.